BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15981929)

  • 1. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S; Danjoux M; Delsol G; Brousset P
    Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
    Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
    J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
    Soslow RA; Bhargava V; Warnke RA
    Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous evaluation of terminal deoxynucleotidyl transferase and myeloperoxidase in acute leukemias using an immunocytochemical method.
    Kaplan SS; Penchansky L; Krause JR; Basford RE; Zdziarski U
    Am J Clin Pathol; 1987 Jun; 87(6):732-8. PubMed ID: 3035914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of TdT positivity in cases of leukemia and lymphoma.
    Drexler HG; Menon M; Minowada J
    Acta Haematol; 1986; 75(1):12-7. PubMed ID: 3088880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
    Orazi A; Cattoretti G; John K; Neiman RS
    Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
    Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
    Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the enzyme terminal deoxyribonucleotidyl transferase in lymphoma and leukemia cells].
    Bombardieri E; Campagnari F; De Braud F; Clerici L; Maiolo AT; Villa ML; Cappelletti V; Saccani Jotti G; Vezzoni P; Neri A
    Acta Biomed Ateneo Parmense; 1984; 55(1):15-23. PubMed ID: 6232800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
    Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
    Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
    Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
    South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
    De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
    Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.
    Maitra A; McKenna RW; Weinberg AG; Schneider NR; Kroft SH
    Am J Clin Pathol; 2001 Jun; 115(6):868-75. PubMed ID: 11392884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification.
    Quintanilla-Martínez L; Zukerberg LR; Ferry JA; Harris NL
    Am J Clin Pathol; 1995 Oct; 104(4):431-43. PubMed ID: 7572794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies that recognize a broad range of mammalian terminal deoxynucleotidyl transferases.
    Smith RG; Baumgarten B
    Hybridoma; 1987 Feb; 6(1):29-45. PubMed ID: 2445652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
    Castella A; Davey FR; Kurec AS; Thompson NA
    Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.
    Liu L; McGavran L; Lovell MA; Wei Q; Jamieson BA; Williams SA; Dirks NN; Danielson MS; Dubie LM; Liang X
    Am J Clin Pathol; 2004 Jun; 121(6):810-5. PubMed ID: 15198352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.